Long Noncoding RNA HEIH Promotes Colorectal Cancer Tumorigenesis via Counteracting miR-939Mediated Transcriptional Repression of Bcl-xL
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Studies have found that long noncoding RNA HEIH (lncRNA-HEIH) is upregulated and facilitates hepatocellular carcinoma tumor growth. However, its clinical significances, roles, and action mechanism in colorectal cancer (CRC) remains unidentified. Materials and Methods lncRNA-HEIH expression in CRC tissues and cell lines was measured by quantitative realtime polymerase chain reaction. Cell Counting Kit-8, ethynyl deoxyuridine incorporation assay, terminal deoxynucleotidyl transferase dUTP nick end labeling staining, and nude mice xenografts assays were performed to investigate the roles of lncRNA-HEIH. RNA pull-down, RNA immunoprecipitation, chromatin immunoprecipitation, and luciferase reporter assays were performed to investigate the action mechanisms of lncRNA-HEIH. Results In this study, we found that lncRNA-HEIH is significantly increased in CRC tissues and cell lines. lncRNA-HEIH expression is positively associated with tumor size, invasion depth, and poor prognosis of CRC patients. Enhanced expression of lncRNA-HEIH promotes CRC cell proliferation and decreases apoptosis in vitro, and promotes CRC tumor growth in vivo. Whereas knockdown of lncRNA-HEIH inhibits CRC cell proliferation and induces apoptosis in vitro, and suppresses CRC tumor growth in vivo. Mechanistically, lncRNA-HEIH physically binds to miR-939. The interaction between lncRNA-HEIH and miR-939 damages the binding between miR-939 and nuclear factor B (NF-B), increases the binding of NF-B to Bcl-xL promoter, and promotes the transcription and expression of Bcl-xL. Moreover, Bcl-xL expression is positively associated with lncRNA-HEIH in CRC tissues. Blocking the interaction between lncRNA-HEIH and miR-939 abolishes the effects of lncRNA-HEIH on CRC tumorigenesis. Conclusion This study demonstrated that lncRNA-HEIH promotes CRC tumorigenesis through counteracting miR-939mediated transcriptional repression of Bcl-xL, and suggested that lncRNAHEIH may serve as a prognostic biomarker and therapeutic target for CRC.
Abstract
Purpose Studies have found that long noncoding RNA HEIH (lncRNA-HEIH) is upregulated and facilitates hepatocellular carcinoma tumor growth. However, its clinical significances, roles, and action mechanism in colorectal cancer (CRC) remains unidentified. Materials and Methods lncRNA-HEIH expression in CRC tissues and cell lines was measured by quantitative realtime polymerase chain reaction. Cell Counting Kit-8, ethynyl deoxyuridine incorporation assay, terminal deoxynucleotidyl transferase dUTP nick end labeling staining, and nude mice xenografts assays were performed to investigate the roles of lncRNA-HEIH. RNA pull-down, RNA immunoprecipitation, chromatin immunoprecipitation, and luciferase reporter assays were performed to investigate the action mechanisms of lncRNA-HEIH. Results In this study, we found that lncRNA-HEIH is significantly increased in CRC tissues and cell lines. lncRNA-HEIH expression is positively associated with tumor size, invasion depth, and poor prognosis of CRC patients. Enhanced expression of lncRNA-HEIH promotes CRC cell proliferation and decreases apoptosis in vitro, and promotes CRC tumor growth in vivo. Whereas knockdown of lncRNA-HEIH inhibits CRC cell proliferation and induces apoptosis in vitro, and suppresses CRC tumor growth in vivo. Mechanistically, lncRNA-HEIH physically binds to miR-939. The interaction between lncRNA-HEIH and miR-939 damages the binding between miR-939 and nuclear factor B (NF-B), increases the binding of NF-B to Bcl-xL promoter, and promotes the transcription and expression of Bcl-xL. Moreover, Bcl-xL expression is positively associated with lncRNA-HEIH in CRC tissues. Blocking the interaction between lncRNA-HEIH and miR-939 abolishes the effects of lncRNA-HEIH on CRC tumorigenesis. Conclusion This study demonstrated that lncRNA-HEIH promotes CRC tumorigenesis through counteracting miR-939mediated transcriptional repression of Bcl-xL, and suggested that lncRNAHEIH may serve as a prognostic biomarker and therapeutic target for CRC.
참고문헌 (26)
- Torre LA, "Global cancer statistics, 2012", CA Cancer J Clin, 65, pp.87~108 (2015)[DOI]
- He D, "Analyzing large-scale samples highlights significant association between rs10411210 polymorphism and colorectal cancer", Biomed Pharmacother, 74, pp.164~168 (2015)[DOI]
- Levy J, "Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth", Nat Cell Biol, 17, pp.1062~1073 (2015)[DOI]
- Li Y, "Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer", Mol Cancer, 15, pp.55~ (2016)[DOI]
- Depeille P, "RasGRP1 opposes proliferative EGFRSOS1-Ras signals and restricts intestinal epithelial cell growth", Nat Cell Biol, 17, pp.804~815 (2015)[DOI]
- Markowitz SD, "Molecular origins of cancer: Molecular basis of colorectal cancer", N Engl J Med, 361, pp.2449~2460 (2009)[DOI]
- Djebali S, "Landscape of transcription in human cells", Nature, 489, pp.101~108 (2012)[DOI]
- Yuan JH, "A long noncoding RNA activated by TGF-beta promotes the invasionmetastasis cascade in hepatocellular carcinoma", Cancer Cell, 25, pp.666~681 (2014)[DOI]
- Mercer TR, "Long non-coding RNAs: insights into functions", Nat Rev Genet, 10, pp.155~159 (2009)[DOI]
- Liu X, "LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress", Nat Cell Biol, 18, pp.431~442 (2016)[DOI]
- Lin A, "The LINK-A lncRNA activates normoxic HIF1alpha signalling in triplenegative breast cancer", Nat Cell Biol, 18, pp.213~224 (2016)[DOI]
- Rui Q, "Long noncoding RNA expression patterns in lymph node metastasis in colorectal cancer by microarray", Biomed Pharmacother, 75, pp.12~18 (2015)[DOI]
- Yang F, "Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans", Hepatology, 54, pp.1679~1689 (2011)[DOI]
- Bartel DP, "MicroRNAs: genomics, biogenesis, mechanism, and function", Cell, 116, pp.281~297 (2004)[DOI]
- Ge Y, "Strand-specific in vivo screen of cancer-associated miRNAs unveils a role for miR-21(*) in SCC progression", Nat Cell Biol, 18, pp.111~121 (2016)[DOI]
- Dror S, "Melanoma miRNA trafficking controls tumour primary niche formation", Nat Cell Biol, 18, pp.1006~1017 (2016)[DOI]
- Yuan JH, "The histone deacetylase 4", SP1, Hepatology, pp.2011, 54[DOI]
- Oliverio M, "Dicer1-miR-328-Bace1 signalling controls brown adipose tissue differentiation and function", Nat Cell Biol, 18, pp.328~336 (2016)[DOI]
- Cui C, "Transcriptional regulation of gene expression by microRNAs as endogenous decoys of transcription factors", Cell Physiol Biochem, 33, pp.1698~1714 (2014)[DOI]
- Chen HC, "An interconnected hierarchical model of cell death regulation by the BCL-2 family", Nat Cell Biol, 17, pp.1270~1281 (2015)[DOI]
- Zheng X, "Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation", Biomed Pharmacother, 83, pp.212~220 (2016)[DOI]
- Feng M, "Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-kappaB-dependent activation of snail and epithelial mesenchymal transition", Mol Cancer, 15, pp.77~ (2016)[DOI]
- Zhang M, "Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis", Biomed Pharmacother, 80, pp.73~79 (2016)[DOI]
- Zhu XT, "Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3", FEBS J, 283, pp.3739~3754 (2016)[DOI]
- Place RF, "MicroRNA-373 induces expression of genes with complementary promoter sequences", Proc Natl Acad Sci U S A, 105, pp.1608~1613 (2008)[DOI]
- Zhang JX, "Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf", MEK, Mol Cancer, pp.2017, 16[DOI]